{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:16:02Z","timestamp":1778033762511,"version":"3.51.4"},"reference-count":22,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2023,7,7]]},"DOI":"10.18632\/oncotarget.28475","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:03:04Z","timestamp":1688734984000},"page":"703-708","source":"Crossref","is-referenced-by-count":5,"title":["Intrathoracic synovial sarcoma with BRAF V600E mutation"],"prefix":"10.18632","volume":"14","author":[{"given":"Ida","family":"Russo","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Barresi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Di Paolo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Di Ruscio","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Del Baldo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Serra","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Vallese","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Miele","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Alaggio","sequence":"additional","affiliation":[{"name":"Department of Pathology, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Maria","family":"Milano","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Gene and Cellular Therapy, Bambino Ges\u00f9 Children's Hospital IRCCS, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/era.11.209","article-title":"The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view","volume":"1","author":"Casanova","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2015.09.010","article-title":"The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study","volume":"4","author":"Yoshida","year":"2016","journal-title":"Hum Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.humpath.2012.08.014","article-title":"A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics","volume":"4","author":"Tsokos","year":"2013","journal-title":"Hum Pathol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.002","article-title":"The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma","volume":"3","author":"Tsai","year":"2018","journal-title":"Cancer Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ccell.2018.01.018","article-title":"The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma","volume":"3","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2159-8290.CD-14-1246","article-title":"Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy","volume":"5","author":"Ladanyi","year":"2015","journal-title":"Cancer Discov"},{"key":"7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/annonc\/mdu562","article-title":"Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)","volume":"2","author":"Bergeron","year":"2015","journal-title":"Ann Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1016\/j.ejca.2012.06.017","article-title":"Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma","volume":"4","author":"Bisogno","year":"2012","journal-title":"Eur J Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.2147\/CMAR.S368381","article-title":"Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)","volume":"1","author":"Gatz","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"37","author":"Judson","year":"2012","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","article-title":"Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]","volume":"2","author":"Hensley","year":"2007","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"4","author":"Dodd","year":"2009","journal-title":"Eur J Cancer"},{"key":"13","unstructured":"https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"key":"14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/pbc.25001","article-title":"Synovial sarcoma relapses in children and adolescents: prognostic factors, treatment, and outcome","volume":"6","author":"Orbach","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1245\/s10434-016-5535-2","article-title":"Synovial Sarcoma Recurrence in Children and Young Adults","volume":"2","author":"Koscielniak","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"2","author":"Schram","year":"2017","journal-title":"Nat Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"36","author":"Chapman","year":"2010","journal-title":"N Engl J Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations","volume":"37","author":"Italiano","year":"2015","journal-title":"N Engl J Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/2159-8290.CD-19-1265","article-title":"Pan-Cancer Efficacy of Vemurafenib in BRAF (V600)-Mutant Non-Melanoma Cancers","volume":"1","author":"Sherman","year":"2020","journal-title":"Cancer Discov"},{"key":"20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41379-020-0530-3","article-title":"BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma","volume":"3","author":"Yoshida","year":"2020","journal-title":"Mod Pathol"},{"key":"21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41591-019-0424-4","article-title":"Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial","volume":"2","author":"Miller","year":"2019","journal-title":"Nat Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"2","author":"Webster","year":"2019","journal-title":"Nat Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:03:08Z","timestamp":1688734988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,7]]}},"alternative-id":["28475"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28475","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}